"Pioneer Research Solutions, (PRS) was established in 2007 with the aim to provide a comprehensive network of practicing physicians dedicated to achieve better results and patient outcome. PRS is a premium provider of Innovative and cost effective business solutions for the Clinical Research market. PRS specializes in providing support services to community Physicians for Business Development, Patient Recruitment, Contracts and Legal, Accounting, Site Training and Trial Management Services."

During the past decade, Pioneer Research Solutions INC conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 64 clinical trials were completed, i.e. on average, 94.1% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 40 clinical trials were completed. i.e. 148.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pioneer Research Solutions INC" #1 sponsor was "Pfizer" with 15 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Galapagos NV" with 4 trials sponsored. Other sponsors include 67 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pioneer Research Solutions INC" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator and "Quintiles, Inc." with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Pioneer Research Solutions INC" are "Rheumatoid Arthritis" (13 trials), "Osteoarthritis" (6 trials), "Asthma" (5 trials), "Chronic Idiopathic Constipation" (5 trials) and "Psoriatic Arthritis" (4 trials). Many other conditions were trialed in "Pioneer Research Solutions INC" in a lesser frequency.

Most popular intervention types in "Pioneer Research Solutions INC" are "Drug" (95 trials), "Other" (17 trials), "Biological" (10 trials), "Combination Product" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (61 trials), "Methotrexate" (4 trials), "Baricitinib" (3 trials), "Guselkumab" (3 trials) and "ARO-APOC3" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pioneer Research Solutions INC" are 101 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Pioneer Research Solutions INC". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 72 completed trials in Pioneer Research Solutions INC, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Pioneer Research Solutions INC, 0 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".